BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34331472)

  • 1. Impurity profiling and stability-indicating method development and validation for the estimation of assay and degradation impurities of midostaurin in softgel capsules using HPLC and LC-MS.
    Lakka NS; Kuppan C; Ravinathan P
    Biomed Chromatogr; 2021 Dec; 35(12):e5222. PubMed ID: 34331472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation pathways and impurity profiling of the anticancer drug apalutamide by HPLC and LC-MS/MS and separation of impurities using Design of Experiments.
    Lakka NS; Kuppan C; Vadagam N; Reddamoni SY; Muthusamy C
    Biomed Chromatogr; 2023 Feb; 37(2):e5549. PubMed ID: 36409057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of novel RP-HPLC method for midostaurin determination using analytical quality by design approach from regulatory perspective and determination of major degradation compounds of midostaurin using LC-MS.
    Reddy Saddala MP; Konduru N; Gundla R; Kowtharapu LP
    Biomed Chromatogr; 2022 Dec; 36(12):e5486. PubMed ID: 36001450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability Indicating RP-HPLC Method for Estimation of Potential Impurities in Ledipasvir and Characterization of a New Degradation Impurity.
    Siva Kumar R; Sravan Kumar KV; Kondareddy L; Yogeshwara KR; Manish G; Jeenet J; Nitesh K
    J Chromatogr Sci; 2018 May; 56(5):383-395. PubMed ID: 29474520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability-indicating method development and validation for quantitative estimation of assay and organic impurities of antiviral drug baloxavir marboxil in drug substance and pharmaceutical dosage form using HPLC and LC-MS methods.
    Nagulancha BR; Lakka NS; Vandavasi KR
    Biomed Chromatogr; 2023 Aug; 37(8):e5644. PubMed ID: 37052118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Elucidation of Novel Degradation Impurity and Development, Validation of a Single HPLC Method for all Putative Impurities of Clobetasol Propionate in a Foam Drug Product.
    Ketha NVDP; Kolli D; Subbappa PK
    J Chromatogr Sci; 2024 May; 62(5):444-453. PubMed ID: 36857571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability-indicating liquid chromatography method development and validation for impurity profiling of montelukast sodium in bulk drug and tablet dosage form.
    Pasham M; Haridasyam SB; Boppy NVVDP; Venkatanarayana M; Palakurthi AK
    Biomed Chromatogr; 2022 Apr; 36(4):e5330. PubMed ID: 34994006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC method development, validation, and impurity characterization of a potent antitumor indenoisoquinoline, LMP776 (NSC 725776).
    Wang J; Liu M; Yang C; Wu X; Wang E; Liu P
    J Pharm Biomed Anal; 2016 May; 124():267-273. PubMed ID: 26970596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RP-LC Method Development and Validation for Dasatinib Forced Degradation Study: Isolation and Structural Characterization by NMR and HRMS.
    Kavitapu DR; Murty JNSRC; Maruthapillai A; Senadi GC; Mahapatra S
    J Chromatogr Sci; 2024 Apr; 62(4):347-355. PubMed ID: 37340779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an efficient stability-indicating LC-MS/MS method for the analysis of selexipag and characterization of its degradation products.
    Amara Babu NLA; Koganti K; Palakeeti B; Srinivas KSV; Rao KP
    Biomed Chromatogr; 2021 Oct; 35(10):e5178. PubMed ID: 33998014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a stability-indicating HPLC method of etifoxine with characterization of degradation products by LC-MS/TOF, 1H and 13C NMR.
    Djabrouhou N; Guermouche MH
    J Pharm Biomed Anal; 2014 Nov; 100():11-20. PubMed ID: 25117950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability-indicating HPLC method for quantification of celecoxib and diacerein along with its impurities in capsule dosage form.
    Bapatu HR; Maram RK; Murthy RS
    J Chromatogr Sci; 2015 Jan; 53(1):144-53. PubMed ID: 24837233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability-indicating HPLC method for simultaneous quantification of 14 impurities in excedrin tablet formulations and identification of new impurity by LC-MS in accelerated stability studies.
    Dongala T; Katari NK; Palakurthi AK; Jonnalagadda SB
    Biomed Chromatogr; 2019 Oct; 33(10):e4608. PubMed ID: 31145484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical method development and validation for the analysis of verapamil hydrochloride and its related substances by using ultra perfomance liquid chromatography.
    Vijayabaskar S; Mahalingam V; Kalaivani
    J Pharm Biomed Anal; 2017 Apr; 137():189-195. PubMed ID: 28131058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability-indicating HPLC method development and validation of rivaroxaban impurities and identification of forced degradation products using LC-MS/MS.
    Cholleti V; Ravindra Kumar Y; Pasula A; Surya PRP
    Biomed Chromatogr; 2022 Sep; 36(9):e5424. PubMed ID: 35697473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validated stability-indicating RP-HPLC assay method for Amsacrine and its related substances.
    Devi ML; Chandrasekhar KB; Surendranath KV; Rao BM; Narayana MB
    J Chromatogr Sci; 2011 Aug; 49(7):489-94. PubMed ID: 21801478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.